While its growth was overshadowed in 2025 by A.I., the biotech sector grew signifcantly and 2026 looks for the trend to ...

Looking back on biotechnology stocks’ Q4 earnings, we examine this quarter’s best and worst performers, including Incyte ...

This little-known biotech could have a big hit on its hands with VK2735, a GLP-1 weight loss drug candidate.

The next 10 months might be challenging for this biotech.

The biotech sector is one that's become red-hot, at least in recent years. After around a decade of stagnation, investors appear to be intent on increasing their exposure to top biotech names in the ...

Adam Feuerstein, a senior writer and biotech columnist, is the author of Adam’s Biotech Scorecard, a subscriber-only ...

This Boston-based biotech develops therapies for neurological disorders, with a pipeline targeting depression, tremor, and ...

This biotech firm develops targeted oncology therapies and leverages proprietary technology to address tumor resistance ...

Learning how to trade biotech stocks offers some of the most explosive profit opportunities in the entire market—but also some of its most punishing risks. Biotech stocks can double or triple ...

(ZBIO) saw substantial insider buying from both its CEO and a director. Chief Executive Officer Leon O. Moulder Jr. reported purchasing shares of common stock in two transactions, with a total value ...

After several years of IPO drought in the biotech industry, the public market is picking up again. Will the trend keep going ...